Patents by Inventor Brigitta-Maria Liechty

Brigitta-Maria Liechty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9127044
    Abstract: The present application relates to cyclic depsipeptides, or derivatives thereof, having the structure of formula (I), and uses thereof, e.g. as inhibitors of kallikrein 7 and human neutrophil elastase.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: September 8, 2015
    Assignee: NOVARTIS AG
    Inventors: Philipp Krastel, Brigitta-Maria Liechty, Josef Gottfried Meingassner, Esther Schmitt, Erwin Paul Schreiner
  • Patent number: 8415305
    Abstract: The present application relates to cyclic depsipeptides of Formula I: or derivatives thereof, wherein X, A1, A2, A3, A4, A5, A6 and A7 are defined herein. The cyclic depsipeptides of Formula I are inhibitors of kallikrein 7 and thus can be employed for the treatment of kallikrein-7 dependent diseases.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: April 9, 2013
    Assignee: Novartis AG
    Inventors: Philipp Krastel, Brigitta-Maria Liechty, Esther Schmitt, Erwin Paul Schreiner
  • Publication number: 20120196790
    Abstract: The present application relates to cyclic depsipeptides, or derivatives thereof, having the structure of formula (I), and uses thereof, e.g. as inhibitors of kallikrein 7 and human neutrophil elastase.
    Type: Application
    Filed: February 14, 2012
    Publication date: August 2, 2012
    Applicant: NOVARTIS AG
    Inventors: Philipp KRASTEL, Brigitta-Maria LIECHTY, Josef Gottfried MEINGASSNER, Esther SCHMITT, Erwin Paul SCHREINER
  • Patent number: 8178650
    Abstract: The present application relates to cyclic depsipeptides, or derivatives thereof, having the structure of formula (I), and uses thereof, e.g. as inhibitors of kallikrein 7 and human neutrophil elastase.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: May 15, 2012
    Assignee: Novartis AG
    Inventors: Philipp Krastel, Brigitta-Maria Liechty, Josef Gottfried Meingassner, Esther Schmitt, Erwin Paul Schreiner
  • Publication number: 20120034650
    Abstract: The present invention relates to the provision of a polynucleotide comprising one or more functional fragments of a biosynthetic gene cluster involved in the production of a compound of formula (I) or (I?). The present invention also provides a method of preparing a compound of formula (I) or (I?) or of formula (II) to (VII), (XI) to (XIV) and (XVII) and (XVIII). Moreover, the use of such compound as a pharmaceutical composition is also provided in the present invention.
    Type: Application
    Filed: February 11, 2010
    Publication date: February 9, 2012
    Applicant: NOVARTIS AG
    Inventors: Philipp Krastel, Brigitta-Maria Liechty, Charles Moore, Esther Schmitt
  • Publication number: 20110092437
    Abstract: The present application relate to cyclic depsipeptides, or derivatives thereof, having the formula (I), and uses thereof, e.g. as inhibitors of kallikrein 7.
    Type: Application
    Filed: August 14, 2008
    Publication date: April 21, 2011
    Inventors: Philipp Krastel, Brigitta-Maria Liechty, Esther Schmitt, Erwin Paul Schreiner
  • Publication number: 20090156472
    Abstract: The present application relates to cyclic depsipeptides, or derivatives thereof, having the structure of formula (I), and uses thereof, e.g. as inhibitors of kallikrein 7 and human neutrophil elastase.
    Type: Application
    Filed: August 18, 2008
    Publication date: June 18, 2009
    Inventors: Philipp Krastel, Brigitta-Maria Liechty, Joseph Gottfried Meingassner, Esther Shmitt, Erwin Paul Schreiner